Labor Market Pulse

VT NONMETROPOLITAN AREA Edition

Focus: LIFE SCI

Vermont's shrinking labor force collides with rising clinical pay.

-2.2% YoY

Vermont labor force change

Driven mainly by retirements, not layoffs

2.3%–3.2%

Nonmetro county unemployment range

Addison/Caledonia low, Essex/Orleans high

$136,574 vs $90,956

CRA advertised pay, metro vs. national

Metro up significantly, outpaces national median

2.6%

Vermont statewide unemployment

Third-lowest in U.S. as of August 2026

This Month's Takeaways

01

Vermont's labor force shrinkage is demographic, not economic.

Retirements, not layoffs, account for most of the roughly 2.2% annual labor force decline statewide. Life Sci leaders should plan headcount growth assuming the candidate pool keeps contracting regardless of hiring budget or market conditions.

02

Regulatory and CMC scarcity is a Vermont-specific build constraint.

Rocket Pharma's Director of Regulatory Affairs–CMC posting at $204K–$264K reflects a national bottleneck landing hard in a thin local market. Expect regulatory roles to require above-market offers or out-of-state recruiting regardless of CDMO availability nearby.

03

Local lab technician pay is falling even as national rates hold up.

Metro median advertised pay for Lab Technicians sits at $40,930, down significantly, against a national median of $47,402 also trending down moderately. Compressed entry-level lab wages may support internal QA staffing but risk turnover to neighboring metros or remote-friendlier employers.

04

Clinical Research Associate pay is rising sharply against a thin field.

Metro CRA median pay of $136,574 is up significantly and now exceeds the national median of $90,956 by a wide margin. A small local candidate pool combined with active CRO/CDMO demand (Charles River, Rocket Pharma) is pushing employers to bid well above national norms to fill clinical roles.

Local Labor Conditions

Vermont's nonmetro counties show a labor force contracting under structural pressure rather than cyclical softness — statewide labor force fell roughly 2.2% year-over-year through mid-2026, driven primarily by retirements rather than layoffs. County unemployment across nonmetro Vermont ranges narrow, from 2.3% in Addison and Caledonia to 3.2% in Essex and Orleans, leaving employers in gene therapy, contract research, and diagnostics competing for a shrinking, already-tight talent pool with no slack building anywhere nearby.

Leadership & Talent Implications

Shrinking labor supply across nonmetro Vermont counties means Life Sci employers cannot count on population growth or inbound migration to ease specialized hiring — Rocket Pharma's Winooski regulatory recruitment at $204K–$264K and Charles River's East Thetford contract operations both depend on a talent base that is structurally not growing. Build-vs-outsource tradeoffs tilt further toward CDMO/CRO partnerships for roles where statewide scarcity is acute (regulatory CMC, cell/gene specialists), while routine QA and clinical support functions remain more defensible to staff internally given compressed lower-end wage bands. Organizations should evaluate which regulatory and manufacturing roles justify premium retention investment locally versus which can shift to contract partners already embedded in the Vermont ecosystem.

Advertised Pay Indicators

Role	P25	Median	P75	Local Trend	National	Nat. Trend
Research Scientist	$109,700	$152,502	$152,503	↓ Moderate decline	$131,354	↑ Significant increase
Clinical Research Associate	$123,155	$136,574	$138,772	↑ Significant increase	$90,956	↑ Significant increase
Lab Technician	$39,286	$40,930	$41,870	↓ Significant decline	$47,402	↓ Moderate decline
Regulatory Affairs Specialist	$86,099	$95,902	$100,000	→ Stable	$104,000	→ Stable
Clinical Data Manager	$83,968	$101,447	$108,998	↓ Significant decline	$123,031	↓ Moderate decline
Biostatistician	$106,453	$144,208	$144,343	↓ Significant decline	$133,322	↑ Moderate increase
Validation Engineer	—	—	—	— No data	$108,377	↑ Moderate increase

Some roles reflect state-level data where local metro sample size was insufficient.

Looking Ahead · Next 30–60 Days

Potential inflection point

Vermont's Right to Collective Bargaining constitutional amendment appears on the November 2026 ballot with roughly 65% polling support. A pro-labor shift could reshape compensation negotiation dynamics for manufacturing and R&D staff at Vermont-based biotech and CDMO employers.

Emerging pressure point

UVM Health Network layoffs announced earlier in 2026 will not be felt until October, potentially releasing clinical and quality-adjacent talent into a market with almost no slack. Watch whether this cohort absorbs into Life Sci employers or exits the state entirely.

Worth watching

CRA and Biostatistician advertised pay are moving in opposite directions locally — CRA up significantly, Biostatistician down significantly to $144,208. Divergence this sharp across adjacent clinical functions warrants a fresh look at role-specific offers rather than blanket clinical pay adjustments.

Early indicator

Manufacturing WARN activity tied to Franklin County dairy processors signals continued erosion of Vermont's broader manufacturing base. Monitor whether displaced skilled production workers migrate toward biomanufacturing and CMC roles, a potential but unproven talent pipeline.

WageScape Member Benefit

Monitor more markets, industries, and job families.

Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.

Pulse Plus

3 metro reports

$149/year

Pulse Pro

10 metro reports

$349/year

Enterprise

10+ markets

Contact us

Scan or click to add coverage

WageTrak · 15% Member Discount

On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.

Forwarded This Briefing?

Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.